A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

MeningitisMeningococcal InfectionMeningococcemiaNeisseria Meningitidis

Phase 2

Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age

CompletedNCT00643916

Sanofi Pasteur, a Sanofi CompanyMeningitis, Meningococcal Infection

Start: 2004-12-31End: 2007-10-31Updated: 2014-02-14

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

CompletedNCT00772070

Sanofi Pasteur, a Sanofi CompanyMeningitis, Meningococcemia, Neisseria Meningitidis

Start: 2003-03-31End: 2004-05-31Updated: 2014-02-14